New research aims to decipher how animals discard half their genes

New research is underway to decipher a fascinating biological puzzle-;how some animals can naturally discard more than half of their genetic information during embryonic development.

This radical natural phenomenon has captivated scientists for over 130 years, presenting a tantalizing question in the field of developmental biology and genetics.

Equipped with the latest in genetic engineering tools, the team at The University of Warwick is working to dissect the mechanisms behind this selective genomic editing. By uncovering the processes that allow some nematode worms to abandon up to 60% of the genetic material of some of their cells, the researchers hope to develop biotechnological tools that could enable large-scale, precise genomic alterations. These can be applied in different areas – from engineering models of hereditary diseases, helping to drive medical advancements and treatments, to improving crop resilience to harsh environmental conditions in the agricultural industry.

The new study is part of the Biotechnology and Biological Sciences Research Council's (BBSRC) Pioneer Awards, which could revolutionise our understanding of the rules of life. Sixty two researchers across the UK, including Professor Andre Pires da Silva at the University of Warwick, are to receive a share of £12 million to pursue visionary bioscience research.

By drawing upon unconventional thinking and approaches, the investigators hope to make exciting discoveries with the potential to transform our understanding of the fundamental rules of life. These new investigations aim to radically change the way we think about important biological phenomena covering plant, microbial and animal sciences.

The investment by the Biotechnology and Biological Sciences Research Council's (BBSRC) Pioneer Awards enables the pursuit of unique ideas that challenge current thinking and paradigms or open up entirely novel areas of exploration altogether.

Professor Andre Pires da Silva, School of Life Sciences, University of Warwick, said: "Funding opportunities for curiosity-driven studies have led to several important discoveries with practical applications. This includes the development of the polymerase chain reaction (PCR) technique, which is now widely used in biomedical research for amplifying DNA. The BBSRC is giving us a tremendous chance to explore a unique way of genome regulation, which may also help in building new tools to help areas such as medicine and agriculture."

Understanding the fundamental rules of life, such as the principles governing genetics, evolution and biological processes, is essential for advancing scientific knowledge. It is also imperative to societal progress.

Many of the challenges faced by today's society, such as global food security, environmental sustainability and healthcare, are deeply rooted in biological processes.

BBSRC is committed to understanding the rules of life and by investing in cutting-edge discovery research through schemes such as the Pioneer Awards pilot, we are expanding the horizons of human knowledge while helping to unlock innovative bio-based solutions to some of the world's most pressing challenges."

Professor Guy Poppy, Interim Executive Chair at BBSRC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy